This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Oesophagus
CD2_BENIGN_OESOPHAGUS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum oesophagi
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Oesophagus
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Oesophagus
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 416 | 222 | 194 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.09 |
| Median age at first event (years) | 61.02 | 58.92 | 63.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 383
- Matched controls
- 3828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
4503599627370496.0
323.0
371
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
17.5
131.2
307
716
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
44.7
42
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.5
40
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
+∞
38.2
36
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
17.3
33.8
54
36
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
5.4
29.1
97
226
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
28.8
29.0
39
15
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
39.5
28.9
36
10
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
22.2
27.6
40
20
JN4BD
NOMESCO Finland
Extensive body CT
8.8
25.4
56
73
A04AA02
ATC
granisetron; systemic, transdermal
+∞
25.3
24
*
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
+∞
24.2
23
*
H02AB02
ATC
dexamethasone; systemic
30.5
23.6
31
11
UJD02
NOMESCO Finland
Gastroscopy
8.0
23.1
54
77
R13
ICD-10 Finland
Dysphagia
6.5
23.0
63
113
A02BC02
ATC
pantoprazole; systemic
3.1
21.8
285
1867
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.0
20
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
+∞
21.0
20
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
5.0
20.1
68
157
UJF32
NOMESCO Finland
Coloscopy
3.0
19.6
140
609
A02BC05
ATC
esomeprazole; systemic
2.7
19.3
197
1070
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
18.9
18
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.8
18.4
65
157
WF002
NOMESCO Finland
Radical radiotherapy
99.7
17.7
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
16.8
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
177.4
16.6
17
*
K22.7
ICD-10 Finland
Barrett oesophagus
16.3
16.4
26
17
UJC12
NOMESCO Finland
Flexible oesophagoscopy
31.6
16.3
21
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.1
16.0
30
29
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
15.7
15
*
K22.2
ICD-10 Finland
Oesophageal obstruction
30.0
15.3
20
7
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
15.2
104
428
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
15.0
188
1091
WX402
NOMESCO Finland
General anaesthesia
3.5
15.0
77
259
K22.1
ICD-10 Finland
Ulcer of oesophagus
10.7
14.2
27
27
JN4AD
NOMESCO Finland
Body CT examination
7.2
14.1
34
51
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
A02BC01
ATC
omeprazole; systemic
2.5
13.4
137
707
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
13.2
116
550
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
12.9
70
243
A04AA01
ATC
ondansetron; systemic, rectal
9.8
12.7
25
27
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
12.1
89
380
Z2221
NOMESCO Finland
Medical doctor
2.4
11.9
123
631
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
WX002
NOMESCO Finland
Sedation and analgesia
2.6
11.5
97
444
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
36.2
11.3
14
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
44.7
11.0
13
*
ZXC96
NOMESCO Finland
Robot assisted procedure
61.8
10.7
12
*
A02BC03
ATC
lansoprazole; oral
2.2
10.7
135
757
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
113.0
10.5
11
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
10.5
10
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
C16.00
ICD-10 Finland
Cardia
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.5
10
*
JCA05
NOMESCO Finland
Endoscopic polypectomy in oesophagus
+∞
10.5
10
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
33.5
10.4
13
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
19.4
10.3
15
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
10.1
87
402
R4190
NOMESCO Finland
Nutritional therapy
6.8
9.9
24
37
N02AA05
ATC
oxycodone; systemic
2.8
9.6
63
249
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
9.3
83
389
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.3
327
2726
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
19.2
9.0
13
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
9.0
110
598
K20
ICD-10 Finland
Oesophagitis
8.3
9.0
19
24
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
24.7
9.0
12
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
8.7
77
358
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
8.7
43
140
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
8.6
17
19
L03AA02
ATC
filgrastim; parenteral
92.0
8.4
9
*
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
8.4
8
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
8.4
27
60
Z3231
NOMESCO Finland
Registered nurse
2.1
8.3
111
623
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.0
8.3
32
85
UJC02
NOMESCO Finland
Rigid oesophagoscopy
14.9
8.3
13
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
8.2
141
878
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
8.1
139
864
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
8.0
31
83
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.4
7.8
27
65
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
45.9
7.7
9
*
B01AB05
ATC
enoxaparin; parenteral
2.0
7.7
112
649
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
7.5
69
326
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
7.5
60
266
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
7.4
44
163
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.8
7.4
30
84
R4110
NOMESCO Finland
Physiotherapy
2.0
7.4
103
589
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
7.3
41
144
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
+∞
7.3
7
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
7.3
39
135
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
7.3
97
541
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
7.2
58
257
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
7.2
57
249
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
3.8
7.2
29
81
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
12.3
7.1
12
10
WX600
NOMESCO Finland
Single shot through catheter
12.3
7.1
12
10
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
7.1
48
191
B01AB10
ATC
tinzaparin; parenteral
3.9
6.9
27
73
K90.0
ICD-10 Finland
Coeliac disease
5.2
6.9
20
40
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
6.9
146
965
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
6.8
97
556
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
40.8
6.8
8
*
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
40.8
6.8
8
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.9
6.7
26
70
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.9
6.7
26
70
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.8
6.7
21
46
N03AX16
ATC
pregabalin; oral
2.0
6.7
98
569
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.8
6.5
20
43
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
71.0
6.4
7
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.3
6.4
18
35
K30
ICD-10 Finland
Functional dyspepsia
2.6
6.4
47
198
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.2
6.3
8
*
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
27.2
6.3
8
*
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
27.2
6.3
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
6.2
37
139
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
7.9
6.2
13
17
S18
ICPC
Laceration/cut
1.8
6.2
151
1037
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
6.1
33
116
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
10.3
6.1
11
11
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.1
63
317
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
177
462
5.93
68.35
2.1
1.2
—
—
—
0
0
(4035726)
55
87
7.13
34.22
1.5
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
86
230
4.45
29.95
2.7
1.8
g/l
0.2
0.2
0.27
78
206
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
277
1572
3.28
29.18
7.8
3.7
umol/l
11.1
11.4
0.22
266
1465
(3024561) Albumin [Mass/volume] in Serum or Plasma
249
1334
3.16
28.92
7.7
3.6
g/l
35.1
35.8
0.97
231
1225
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
72
175
4.77
28.20
2.8
1.5
ug/l
7.4
4.6
0.40
64
132
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
353
2455
3.89
24.01
10.2
5.1
u/l
79.5
74.4
2.26
330
2249
(3002256) Pathology report gross observation
75
219
3.96
22.90
1.4
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1014
2.61
20.05
3.0
2.1
u/l
54.4
58.7
0.97
171
933
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
235
1388
2.59
20.04
11.3
4.9
mmol/l
1.2
1.2
0.05
209
1238
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
249
1521
2.59
19.64
12.1
5.6
mmol/l
1.2
1.2
0.12
208
1312
(40768804) Tissue Pathology biopsy report
184
975
2.59
19.60
2.7
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
227
1330
2.56
19.53
12.8
9.6
inr
1.2
1.3
1.02
54
379
(3013650) Neutrophils [#/volume] in Blood by Automated count
267
1696
2.60
19.24
11.5
6.2
e9/l
4.4
4.2
0.54
232
1482
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
160
800
2.63
19.13
2.9
2.1
mg/l
3.1
3.1
0.12
144
666
(3044640) Blood type and Crossmatch panel - Blood
166
857
2.56
18.44
4.3
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
184
1004
2.49
18.08
7.5
5.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
97
391
2.93
17.42
10.6
5.2
mmol/l
1.1
1.0
1.16
90
350
(3022096) Basophils/100 leukocytes in Blood
224
1374
2.37
16.49
7.9
5.3
%
0.7
0.7
0.49
208
1271
(3001604) Monocytes [#/volume] in Blood
242
1541
2.36
16.25
7.6
5.0
e9/l
0.6
0.6
0.05
206
1339
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
219
1338
2.34
16.17
5.3
3.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
242
1551
2.34
15.87
7.6
5.0
e9/l
0.0
0.0
0.07
206
1351
(3019198) Lymphocytes [#/volume] in Blood
244
1571
2.34
15.81
7.6
5.1
e9/l
1.9
1.9
0.10
213
1383
(3002030) Lymphocytes/100 leukocytes in Blood
231
1461
2.31
15.50
8.0
5.3
%
26.2
27.7
1.33
212
1352
(3013115) Eosinophils [#/volume] in Blood
245
1602
2.29
15.00
8.3
5.3
e9/l
0.2
0.2
1.74
214
1415
(3013826) Glucose [Moles/volume] in Serum or Plasma
277
1911
2.35
14.86
9.8
4.0
mmol/l
6.7
6.8
0.23
257
1776
(3006504) Eosinophils/100 leukocytes in Blood
226
1434
2.26
14.83
8.0
5.2
%
2.6
3.0
1.30
210
1325
(3019069) Monocytes/100 leukocytes in Blood
226
1438
2.25
14.68
8.2
5.5
%
8.6
8.6
0.13
209
1339
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
130
663
2.40
14.21
4.4
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
102
469
2.56
13.92
3.5
2.4
umol/l
10.7
13.6
4.27
96
426
(3023368) Bacteria identified in Blood by Culture
147
803
2.28
13.61
6.3
3.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
224
1454
2.17
13.43
8.0
5.1
%
58.7
57.4
0.85
206
1353
(3018418) pH of Serum or Plasma
155
875
2.23
13.17
6.3
3.1
ph
7.4
7.4
0.33
29
143
(3020779) Urea [Moles/volume] in Serum or Plasma
66
255
2.89
12.58
12.6
6.8
mmol/l
9.3
10.2
0.44
59
243
(3022145) Colonoscopy Study observation
77
326
2.67
12.33
1.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
64
253
2.81
11.66
17.2
6.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
384
2.49
11.44
3.8
2.5
%
18.5
24.4
4.15
71
327
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
262
2.76
11.41
2.6
2.0
u/l
34.0
34.4
0.03
48
213
(3015377) Calcium [Moles/volume] in Serum or Plasma
167
1032
2.03
10.75
3.7
2.1
mmol/l
2.3
2.3
0.38
142
852
(3042936) Bacteria identified in Isolate by Culture
91
444
2.34
10.68
2.7
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
206
1383
1.97
10.37
4.2
2.7
ug/l
115.2
125.0
0.25
190
1259
(3027801) Oxygen [Partial pressure] in Arterial blood
78
363
2.41
10.15
16.6
6.3
kpa
11.4
11.6
0.17
72
347
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
78
363
2.41
10.15
16.7
6.4
kpa
5.1
5.1
0.24
72
346
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
332
2.45
9.98
3.2
2.2
umol/l
6.8
7.9
0.27
61
286
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
165
3.01
9.96
14.9
8.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
295
2263
2.04
9.86
4.9
4.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
77
362
2.38
9.78
16.8
6.4
mmol/l
1.3
1.6
0.19
64
283
(3014576) Chloride [Moles/volume] in Serum or Plasma
79
379
2.34
9.57
16.0
5.6
mmol/l
104.1
104.2
0.09
79
369
(3021960) Folate [Moles/volume] in Serum or Plasma
138
828
2.00
9.42
1.8
1.5
nmol/l
21.5
21.4
0.02
124
702
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
1013
1.94
9.32
4.8
2.6
u/l
28.2
31.6
1.27
152
963
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
117
3.27
9.18
1.8
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
199
2.72
8.95
2.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
204
1414
1.87
8.89
2.4
2.0
pmol/l
95.8
95.5
0.03
120
721
(36304419) Bacteria [Presence] in Urine
135
819
1.96
8.83
3.7
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
152
966
1.90
8.62
2.8
3.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
167
1100
1.87
8.43
3.8
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
278
2159
1.87
8.09
4.1
2.8
u/l
55.7
45.7
1.07
247
1994
(3030467) Casts [#/volume] in Urine by Automated count
136
848
1.90
8.08
3.8
2.7
e6/l
0.4
0.5
0.52
101
635
(3018095) Leukocytes [#/volume] in Urine
163
1079
1.84
8.01
4.3
3.4
e6/l
67.7
99.8
0.61
114
764
(3009542) Hematocrit [Volume Fraction] of Blood
356
3016
2.25
7.97
29.6
13.3
%
38.8
40.1
1.79
229
2064
(40758558) Short blood count panel - Blood
119
723
1.90
7.59
7.5
4.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
306
2474
1.90
7.56
5.1
4.1
mm/h
14.9
11.4
2.71
272
2254
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
379
3319
2.60
7.49
26.0
12.0
mg/l
22.5
23.2
0.16
314
2516
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
671
1.92
7.43
4.5
3.9
ng/l
645.6
302.4
0.28
88
537
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
128
2.89
7.32
1.9
1.8
g/l
1.3
1.6
1.16
29
111
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
296
2.24
7.12
3.0
3.3
ng/l
197.5
213.6
0.13
55
274
(3015736) pH of Urine
179
1252
1.75
7.10
3.4
3.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
120
2.90
6.98
1.2
1.3
g/l
3.5
3.9
0.77
24
87
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
120
2.90
6.98
1.2
1.3
g/l
6.9
7.6
1.56
26
91
(3048689) Calprotectin [Mass/mass] in Stool
68
349
2.13
6.91
2.6
2.1
ug/g
138.5
125.0
0.16
48
265
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
219
2.40
6.90
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
139
925
1.75
6.43
3.8
2.9
e6/l
96.7
45.9
0.34
107
712
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
120
2.81
6.41
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
77
427
1.99
6.33
1.2
1.3
titre
301.2
480.4
0.84
17
101
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
88
512
1.91
6.29
3.0
2.5
e6/l
1.0
1.1
0.09
44
290
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
611
1.84
6.13
3.3
2.1
mmol/l
2.5
2.4
0.82
84
517
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
63
3.46
6.08
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
63
3.46
6.08
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
182
1320
1.67
6.07
2.7
2.3
nmol/l
74.0
77.5
0.98
159
1151
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
472
1.92
6.04
3.1
2.7
e6/l
3.1
2.2
0.26
39
250
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
40
4.12
5.95
1.1
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
248
2.20
5.91
4.6
3.7
ng/l
112.0
86.5
0.86
43
218
(3027945) Reticulocytes/100 erythrocytes in Blood
66
355
2.02
5.90
2.7
2.3
%
1.7
1.7
0.04
59
314
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
114
2.76
5.87
1.2
1.3
g/l
3.1
3.1
0.05
25
89
(3007853) Bacteria identified in Skin by Aerobe culture
67
364
2.00
5.82
2.1
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
71
3.22
5.70
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
102
640
1.79
5.69
2.9
2.2
e6/l
6.2
5.2
0.23
91
553
(3035350) Ketones [Presence] in Urine by Test strip
209
1589
1.63
5.68
3.7
3.5
estimate
0.0
0.0
0.00
32
279
(3019309) Folate [Moles/volume] in Red Blood Cells
103
652
1.77
5.57
2.0
1.8
nmol/l
1159.3
1205.9
0.16
74
482
(3021589) Normoblasts [#/volume] in Blood
190
1417
1.63
5.53
13.2
7.9
e9/l
0.0
0.0
0.86
154
1173
(3052851) Hemolysis interference index of Serum or Plasma
23
78
3.06
5.50
2.5
3.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
28
110
2.66
5.16
2.0
1.9
ug/l
412.2
692.9
0.25
28
103
(3021601) Nitrite [Presence] in Urine by Test strip
207
1595
1.59
5.15
5.1
4.7
estimate
0.0
0.0
0.50
33
277
(1616796) Gas panel - Central venous blood
18
55
3.38
5.08
6.9
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
123
841
1.66
4.96
2.7
2.4
umol/l
3647.7
7137.9
0.44
105
723
(3009261) Glucose [Presence] in Urine by Test strip
208
1617
1.57
4.90
3.7
3.5
estimate
0.0
0.0
0.50
31
272
(3002385) Erythrocyte distribution width [Ratio]
318
2737
1.69
4.85
31.2
14.5
%
14.2
13.6
4.67
313
2680
(3026782) Osmolality of Urine
94
604
1.72
4.76
2.8
2.5
mosm/kgh2o
530.6
557.5
0.60
85
495
(3019550) Sodium [Moles/volume] in Serum or Plasma
383
3501
2.18
4.61
31.0
14.5
mmol/l
139.4
139.8
1.91
375
3397
(3044889) 12 lead EKG panel
286
2411
1.60
4.60
4.5
3.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
5
14.20
4.59
2.7
4.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
296
1.95
4.56
4.0
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
224
2.08
4.56
8.0
3.0
mmol/l
1.2
1.2
0.40
38
190
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
350
3115
1.78
4.45
5.7
4.6
mu/l
1.9
2.3
0.51
322
2818
(3023103) Potassium [Moles/volume] in Serum or Plasma
383
3509
2.15
4.45
31.2
14.6
mmol/l
4.0
4.0
0.77
375
3400
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
82
517
1.73
4.43
2.2
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
105
711
1.64
4.33
1.8
1.7
mg/l
1.0
1.0
0.04
79
559
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
97
2.56
4.21
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
66
398
1.78
4.15
1.8
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
90
593
1.66
4.12
1.3
1.2
g/l
2.6
2.6
0.00
49
354
(3002032) Base excess in Venous blood by calculation
54
309
1.86
4.02
4.4
3.1
mmol/l
1.8
2.2
0.32
47
245
(40768443) Skin Pathology biopsy report
26
112
2.41
4.01
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
43
3.33
3.94
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
38
3.50
3.93
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
71
2.76
3.88
1.5
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
66
2.81
3.80
7.2
4.0
mmol/l
3.0
3.0
0.02
12
42
(3000492) Spirometry study
51
292
1.85
3.79
1.6
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
97
2.45
3.72
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
47
265
1.87
3.67
3.1
2.6
e9/l
66.4
66.4
0.00
30
211
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
97
673
1.58
3.57
3.8
4.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
100
2.38
3.49
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
58
2.83
3.46
1.6
1.6
—
—
—
0
0
(3013512) EKG study
136
1026
1.48
3.38
4.7
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
374
1.71
3.36
2.1
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
184
1.99
3.36
2.6
2.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
60
375
1.70
3.33
2.1
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
54
2.84
3.29
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1346
1.44
3.27
4.1
3.6
ng/l
35.0
63.7
0.55
111
953
(3003694) ABO and Rh group [Type] in Blood
106
768
1.51
3.18
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
188
1.94
3.17
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
691
1.53
3.15
1.4
1.2
u/ml
0.5
2.0
1.72
20
198
(3042631) Mycobacterium sp identified in Specimen
11
34
3.30
3.08
1.1
2.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
292
2569
1.46
3.07
4.5
3.7
pmol/l
14.5
14.9
2.07
272
2312
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
137
1052
1.45
3.06
3.0
2.8
ng/l
1477.1
1266.5
0.34
110
877
(3006653) Thiamine [Moles/volume] in Blood
8
16
5.08
3.06
1.1
1.4
nmol/l
121.8
152.5
—
8
16
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
253
1.78
2.95
2.9
2.1
ml/min/173m2
59.4
64.1
0.35
19
100
(3041096) Erythrocytes [Presence] in Urine by Automated
117
877
1.46
2.95
3.0
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
284
1.74
2.95
2.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
(4010399)
44
261
1.77
2.94
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
376
3506
1.75
2.92
23.3
11.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
62
405
1.62
2.92
2.1
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
13
5.46
2.88
1.7
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
1074
1.43
2.84
2.7
2.0
u/l
182.9
236.5
0.34
133
1008
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
18
4.51
2.81
1.6
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
42
2.91
2.77
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
54
2.65
2.73
2.6
2.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
61
2.51
2.65
1.2
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
383
3608
1.78
2.61
15.5
8.6
u/l
25.4
25.6
0.10
368
3455
(40767503) Oxygen content in Capillary blood by calculation
15
62
2.47
2.57
3.1
2.5
%
14.0
16.6
—
8
28
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
44
2.78
2.57
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
88
2.21
2.55
3.6
2.4
u/ml
0.2
0.4
—
8
47
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
156
1263
1.38
2.49
3.8
3.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
21
3.86
2.47
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
357
1.59
2.43
1.9
1.7
%
1.9
1.5
0.96
42
306
(36660697) Celiac disease serology panel - Serum
38
230
1.72
2.40
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
209
1.74
2.32
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
392
3736
1.85
2.30
38.0
17.7
e9/l
254.9
246.8
1.32
383
3623
(3035941) MCH [Entitic mass]
392
3736
1.85
2.30
37.8
17.6
pg
30.2
30.4
0.52
386
3663
(3024731) MCV [Entitic volume]
392
3736
1.85
2.30
37.9
17.7
fl
91.3
91.2
0.31
386
3663
(3011397) Hemoglobin [Presence] in Urine by Test strip
98
742
1.42
2.30
3.9
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
225
1.71
2.30
2.6
4.0
%
0.4
0.8
—
8
52
(3026361) Erythrocytes [#/volume] in Blood
392
3737
1.85
2.28
38.0
17.7
e12/l
4.4
4.5
5.58
379
3613
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
157
1.84
2.28
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
392
3738
1.84
2.27
38.1
17.7
e9/l
7.0
6.6
2.74
380
3618
(3000963) Hemoglobin [Mass/volume] in Blood
392
3739
1.84
2.25
38.3
17.8
g/l
130.9
136.5
9.41
383
3666
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
22
115
1.96
2.20
1.2
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
35
213
1.70
2.18
2.7
4.1
%
0.0
0.1
—
8
45
(3019060) Gas panel - Arterial blood
35
213
1.70
2.18
10.4
4.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
145
1.85
2.16
1.2
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
62
2.30
2.10
1.1
1.2
—
—
—
0
0
(44790047)
9
31
2.94
2.08
1.3
1.3
—
—
—
0
0
(44790048)
9
31
2.94
2.08
1.3
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
9
31
2.94
2.08
1.9
1.2
e6/l
1746.8
2127.8
—
9
19
(44806118)
9
31
2.94
2.08
1.3
1.3
—
—
—
0
0
(44790049)
9
31
2.94
2.08
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
83
2.09
2.04
3.5
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
194
1.70
2.03
2.0
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
71
2.15
1.94
1.7
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
45
2.48
1.94
2.7
2.5
e9/l
5.2
4.3
0.77
11
45
(3025159) Blasts/100 leukocytes in Blood
33
205
1.66
1.93
2.8
4.2
%
0.0
0.0
—
8
41
(4062490)
9
34
2.68
1.87
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
39
255
1.58
1.87
5.0
3.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
46
2.43
1.86
2.8
2.9
%
64.6
56.5
2.17
11
46
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
742
1.36
1.84
1.8
1.7
pmol/l
479.5
29054491.4
0.74
76
592
(3035880) pH of Pleural fluid
5
12
4.20
1.83
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
80
2.04
1.82
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
35
2.61
1.81
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
332
1.50
1.80
2.2
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
47
2.38
1.79
1.1
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
21
117
1.84
1.78
1.4
1.6
—
124.0
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
54
2.26
1.75
1.3
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
18
3.37
1.75
2.0
2.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
103
1.89
1.74
2.8
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
104
1.87
1.70
1.7
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
173
1.66
1.69
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
166
1.67
1.66
1.8
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
25
2.83
1.65
1.9
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
356
3364
1.40
1.65
5.5
4.7
mmol/l
6.0
6.0
0.07
327
3043
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
77
595
1.36
1.60
1.3
1.3
iu/ml
31.1
34.2
0.08
31
183
(3011648) Oxygen content in Venous blood
7
26
2.72
1.58
1.3
1.4
%
10.5
10.6
—
7
26
(3012441) Differential panel - Pleural fluid
7
26
2.72
1.58
1.7
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
206
0.47
1.57
1.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
44
2.30
1.54
1.1
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
202
1.58
1.53
4.5
3.6
mmol/l
3.3
2.0
0.79
24
148
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
15
3.36
1.52
1.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
15
3.36
1.52
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
37
2.46
1.48
3.8
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
66
2.00
1.45
1.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
16
3.15
1.44
1.0
2.5
u/ml
591.0
737.4
—
5
16
(3019225) pH of Specimen
44
315
1.44
1.42
5.6
3.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
74
1.92
1.40
1.9
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
482
1.36
1.40
1.5
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
7
29
2.44
1.40
1.9
1.8
mosm/kgh2o
279.9
275.9
—
7
18
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
67
1.97
1.39
1.5
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
89
1.83
1.39
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
23
2.63
1.37
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
31
209
1.52
1.34
4.7
3.6
ph
7.4
7.4
—
5
21
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
83
1.84
1.33
1.4
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
76
1.87
1.31
1.6
1.7
iu/l
3.2
5.8
—
5
25
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
44
2.07
1.27
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
110
923
1.26
1.26
1.8
1.6
mmol/l
1.3
1.4
0.49
95
773
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
215
1940
1.22
1.26
3.1
2.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
109
1.68
1.21
3.0
2.7
g/l
0.2
0.2
—
7
35
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
26
2.33
1.19
1.2
4.2
—
—
—
0
0
(4281824)
5
20
2.52
1.15
1.4
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
132
1143
1.23
1.13
3.1
3.0
mmol/l
7.4
7.6
0.23
115
943
(1761868) Lipid panel - Serum or Plasma
103
1208
0.80
1.13
3.0
3.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
73
1.81
1.12
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
20
128
1.59
1.10
7.3
4.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
333
3170
1.25
1.05
22.9
11.0
ml/min/173m2
78.4
78.3
0.03
279
2551
(3012516) Albumin [Mass/volume] in Urine
126
1095
1.22
1.04
3.2
3.2
mg/l
1159.5
172.3
0.66
79
700
(3002179) Metamyelocytes/100 leukocytes in Blood
29
207
1.43
0.99
3.0
4.1
%
0.3
0.3
—
7
38
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
282
0.66
0.99
1.9
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
23
2.19
0.98
1.8
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
50
1.82
0.97
2.3
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
77
1.71
0.96
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
51
1.78
0.95
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
37
1.91
0.94
1.1
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
323
1.33
0.94
2.0
2.4
ug/l
4.9
7.2
1.02
37
275
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
28
2.16
0.92
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
94
1.62
0.92
1.3
1.6
—
—
—
0
0
(4034850)
7
126
0.55
0.89
7.6
8.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
42
1.92
0.89
2.1
1.6
%
86.3
90.5
—
8
42
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
43
1.88
0.87
1.1
1.3
nmol/l
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
68
567
1.24
0.84
1.4
1.3
u/ml
31.6
12.4
0.66
29
209
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
47
1.72
0.81
1.1
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
47
1.72
0.81
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
130
1161
1.17
0.78
3.9
3.9
mg/mmol
5.7
7.8
0.56
82
721
(3019150) Specific gravity of Urine by Refractometry
87
753
1.20
0.75
3.9
3.7
kg/l
1.0
1.0
2.12
12
108
(3035637) Corticotropin [Mass/volume] in Plasma
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
39
1.81
0.73
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.3
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
213
1.34
0.70
2.8
2.6
e9/l
3.6
3.9
0.26
17
156
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
334
3220
1.19
0.70
6.5
6.1
mmol/mol
40.0
40.3
0.19
299
2974
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
61
1.66
0.69
9.0
3.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
42
1.68
0.68
1.4
1.4
pmol/l
152.0
359.1
—
7
34
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
442
1.23
0.67
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
372
1.24
0.62
1.6
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
50
1.61
0.61
1.4
1.2
—
75.1
—
0
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
35
1.72
0.58
3.2
2.4
pg
31.0
33.4
—
6
35
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
81
1.50
0.57
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
461
1.20
0.56
4.8
4.8
%
34.1
32.1
0.87
38
296
(3021788) Differential panel - Synovial fluid
9
60
1.51
0.54
2.1
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
11
74
1.50
0.54
4.5
3.6
nmol/l
0.8
0.8
0.01
11
57
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
1.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
336
3268
1.15
0.49
4.1
4.1
mmol/l
1.3
1.3
0.17
301
2963
(3008898) HLA-B27 [Presence]
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
45
1.56
0.49
1.7
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
47
1.50
0.48
1.9
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
47
1.50
0.48
3.7
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
173
1.29
0.47
2.0
3.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
50
1.41
0.45
1.1
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
10
69
1.46
0.44
1.6
1.2
u/l
9.8
9.7
—
10
60
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
69
1.46
0.44
1.8
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.6
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
34
287
1.20
0.41
4.0
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
58
1.39
0.41
1.3
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
59
1.36
0.41
2.4
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
159
1.27
0.41
5.7
3.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
34
1.48
0.40
1.4
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
61
1.32
0.39
1.8
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
80
1.39
0.39
1.3
1.2
—
10.5
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
98
1.34
0.38
2.9
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
69
1.31
0.37
1.3
2.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
77
0.65
0.36
1.8
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
94
869
1.11
0.34
4.6
3.8
estimate
0.0
0.0
0.50
30
274
(3004616) Nuclear Ab [Presence] in Serum
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
46
1.31
0.33
2.7
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
74
1.36
0.32
1.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
347
3406
1.11
0.32
4.6
4.7
mmol/l
4.5
4.6
0.88
317
3128
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
240
1.18
0.31
1.1
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
344
3380
1.10
0.29
4.6
4.6
mmol/l
1.4
1.5
2.50
310
3094
(3045414) Leukocytes [Presence] in Urine
16
131
1.23
0.27
1.3
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
72
0.69
0.26
1.2
1.3
—
218.1
—
0
36
(3019832) Treponema pallidum Ab [Presence] in Serum
22
189
1.17
0.24
1.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
77
1.17
0.24
1.7
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
157
0.82
0.23
2.0
2.8
e6/l
0.1
0.2
0.17
13
151
(3000764) Benzodiazepines [Presence] in Urine
10
79
1.27
0.22
1.7
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
10
0.00
0.21
0.0
1.6
—
15.0
—
0
5
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
103
0.77
0.21
2.4
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
192.7
—
0
13
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
80
1.26
0.20
1.7
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
80
1.26
0.20
1.7
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
231
1.13
0.20
2.0
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
352
3477
1.08
0.20
5.3
5.2
mmol/l
2.7
2.7
0.45
321
3186
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
99
1.22
0.20
1.3
1.2
—
2.9
—
0
16
(21494755) Public health laboratory ask at order entry panel
29
260
1.12
0.20
1.2
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
90
1.23
0.19
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
81
1.24
0.19
1.8
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
1.6
1.4
pmol/l
65.8
58.7
—
7
58
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
119
1.18
0.18
1.3
2.2
—
—
—
0
0
(4094501)
12
101
1.19
0.16
1.2
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
111
1.18
0.16
2.5
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
12
102
1.18
0.15
1.3
1.2
—
3.4
—
0
19
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
80
1.13
0.15
1.4
1.2
—
39.4
—
0
7
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
121
1.16
0.15
2.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
218
0.91
0.10
1.3
1.2
iu/ml
174.8
116.0
—
6
89
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
45
471
0.95
0.09
8.6
6.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
206
0.92
0.09
1.7
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
70
0.86
0.07
1.2
1.2
u/l
123.9
17.3
—
6
62
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
92
0.87
0.07
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
95
0.84
0.06
2.3
4.0
—
—
—
0
0
(1002224) Polysomnography panel
14
150
0.93
0.04
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
65
660
0.98
0.02
2.7
2.6
ug/l
0.5
0.8
2.59
45
423
(3001019) Free T4 and TSH panel - Serum or Plasma
15
144
1.04
0.00
1.3
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
102
0.98
0.00
2.6
2.3
ug/min
31.0
103.3
—
5
63
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
1184
1.00
0.00
4.7
3.8
ug/l
1.4
2.0
3.47
103
1053
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
95
949
1.00
0.00
4.0
3.5
%
21.5
24.0
0.80
44
425
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
205
1.03
0.00
2.0
1.8
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.9
—
1.2
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.3
—
0
8
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.7
—
0
7
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
84
0.95
0.00
1.1
1.2
mmol/l
3.8
3.9
—
8
79
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
18.2
—
0
9
(3044290) Cell count panel - Cerebral spinal fluid
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
8
87
0.92
0.00
1.1
1.2
e6/l
8.0
1468.0
—
8
71
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
28.3
—
0
6
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
5.7
—
0
6
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
3.2
—
0
9
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
154.8
—
0
6
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
8
87
0.92
0.00
1.1
1.1
e6/l
1.6
4.9
—
8
69
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OESOPHAGUS_EXALLC – Benign neoplasm: Oesophagus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).